ArticleFrontiers in pharmacology2026

The impact of NK1 receptor antagonist selection on chemotherapy-related adverse events: a retrospective study of adverse events in paclitaxel or nab-paclitaxel and carboplatin combination therapy with fosnetupitant and aprepitant use.

Kenta Yamaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.